Source comparison
Tesamorelin vs Other GH Protocols: Efficacy Comparison
Choosing the right growth hormone protocol depends on your research objectives. Tesamorelin's mechanism differs fundamentally from direct GH administration and other secretagogues. Tesamorelin GHRH receptor agonist. Stimulates natural GH pulses 2mg SC daily 15
This comparison does not assign a generated winner or score.
- Choosing the right growth hormone protocol depends on your research objectives. Tesamorelin's mechanism differs fundamentally from direct GH administration and other secretagogues.
- Tesamorelin
- GHRH receptor agonist. Stimulates natural GH pulses
- 2mg SC daily
- 15.2% (peer-reviewed)
- None. Preserves pituitary function
- Best option for visceral fat reduction without suppressing natural GH axis; requires daily injection discipline
- Ipamorelin
- Ghrelin mimetic. Triggers GH release via growth hormone secretagogue receptor
- 200–300mcg SC 2–3x daily
- 8–12% (observational data)
- Minimal at standard doses
- Flexible dosing but requires multiple daily injections; less clinical validation than tesamorelin
- CJC-1295 + Ipamorelin
- GHRH analogue + ghrelin mimetic. Dual-pathway stimulation
- 100mcg CJC / 200mcg Ipa SC daily
- 10–14% (observational)
- Minimal
- Popular research stack; CJC's extended half-life reduces injection frequency vs ipamorelin alone
- Recombinant GH (rhGH)
- Direct GH replacement. Bypasses endogenous production
- 2–4 IU SC daily
- 18–22%
- Complete. Pituitary shuts down natural GH secretion
- Most potent VAT reduction but suppresses endogenous production; requires post-cycle recovery protocols
- MK-677 (oral)
- Ghrelin receptor agonist. Oral GH secretagogue
- 10–25mg oral daily
- 6–9%
- None
- Oral convenience but weakest VAT effect; significant water retention and appetite stimulation
- Tesamorelin's advantage is preserved pituitary function. When you stop, natural GH secretion resumes immediately without a suppression period. Direct GH protocols require tapering and post-cycle support to restart endogenous production.